191 related articles for article (PubMed ID: 25157404)
1. Proliferation index: a continuous model to predict prognosis in patients with tumours of the Ewing's sarcoma family.
Brownhill S; Cohen D; Burchill S
PLoS One; 2014; 9(8):e104106. PubMed ID: 25157404
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical analysis and prognostic significance of PD-L1, PD-1, and CD8+ tumor-infiltrating lymphocytes in Ewing's sarcoma family of tumors (ESFT).
Machado I; López-Guerrero JA; Scotlandi K; Picci P; Llombart-Bosch A
Virchows Arch; 2018 May; 472(5):815-824. PubMed ID: 29445891
[TBL] [Abstract][Full Text] [Related]
3. Hypoalbuminaemia is an independent predictor of poor outcome in metastatic Ewing's sarcoma family of tumours: a single institutional experience of 150 cases treated with uniform chemotherapy protocol.
Biswas B; Rastogi S; Khan SA; Shukla NK; Deo SV; Agarwala S; Sharma DN; Thulkar S; Vishnubhatla S; Pathania S; Bakhshi S
Clin Oncol (R Coll Radiol); 2014 Nov; 26(11):722-9. PubMed ID: 24919857
[TBL] [Abstract][Full Text] [Related]
4. A systematic review of molecular and biological markers in tumours of the Ewing's sarcoma family.
Riley RD; Burchill SA; Abrams KR; Heney D; Sutton AJ; Jones DR; Lambert PC; Young B; Wailoo AJ; Lewis IJ
Eur J Cancer; 2003 Jan; 39(1):19-30. PubMed ID: 12504654
[TBL] [Abstract][Full Text] [Related]
5. Ewing's sarcoma family tumours. Differences in clinicopathological characteristics at presentation between localised and metastatic tumours.
Bacci G; Balladelli A; Forni C; Longhi A; Serra M; Fabbri N; Alberghini M; Ferrari S; Benassi MS; Picci P
J Bone Joint Surg Br; 2007 Sep; 89(9):1229-33. PubMed ID: 17905963
[TBL] [Abstract][Full Text] [Related]
6. Factors affecting survival outcomes of patients with non-metastatic Ewing's sarcoma family tumors in the spine: a retrospective analysis of 63 patients in a single center.
Wan W; Lou Y; Hu Z; Wang T; Li J; Tang Y; Wu Z; Xu L; Yang X; Song D; Xiao J
J Neurooncol; 2017 Jan; 131(2):313-320. PubMed ID: 27752884
[TBL] [Abstract][Full Text] [Related]
7. Apoptotic responsiveness of the Ewing's sarcoma family of tumours to tumour necrosis factor-related apoptosis-inducing ligand (TRAIL).
Van Valen F; Fulda S; Truckenbrod B; Eckervogt V; Sonnemann J; Hillmann A; Rödl R; Hoffmann C; Winkelmann W; Schäfer L; Dockhorn-Dworniczak B; Wessel T; Boos J; Debatin KM; Jürgens H
Int J Cancer; 2000 Oct; 88(2):252-9. PubMed ID: 11004677
[TBL] [Abstract][Full Text] [Related]
8. Interactomic approach for evaluating nucleophosmin-binding proteins as biomarkers for Ewing's sarcoma.
Haga A; Ogawara Y; Kubota D; Kitabayashi I; Murakami Y; Kondo T
Electrophoresis; 2013 Jun; 34(11):1670-8. PubMed ID: 23483572
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of histopathology in Ewing's sarcoma. Long-term follow-up of distal extremity primary tumors.
Hartman KR; Triche TJ; Kinsella TJ; Miser JS
Cancer; 1991 Jan; 67(1):163-71. PubMed ID: 1985713
[TBL] [Abstract][Full Text] [Related]
10. [Efficacy and survival of 92 cases of Ewing's sarcoma family of tumor initially treated with multidisciplinary therapy].
Peng RJ; Sun XF; Xiang XJ; Zhen ZJ; Ling JY; Tong GL; Xia Y; Xu GC; Jiang WQ
Ai Zheng; 2009 Dec; 28(12):1304-9. PubMed ID: 19958626
[TBL] [Abstract][Full Text] [Related]
11. Ewing's sarcoma: diagnostic, prognostic, and therapeutic implications of molecular abnormalities.
Burchill SA
J Clin Pathol; 2003 Feb; 56(2):96-102. PubMed ID: 12560386
[TBL] [Abstract][Full Text] [Related]
12. Chromosome 9p21 gene copy number and prognostic significance of p16 in ESFT.
Brownhill SC; Taylor C; Burchill SA
Br J Cancer; 2007 Jun; 96(12):1914-23. PubMed ID: 17533400
[TBL] [Abstract][Full Text] [Related]
13. Prognostic factors in Ewing's tumor of bone: analysis of 975 patients from the European Intergroup Cooperative Ewing's Sarcoma Study Group.
Cotterill SJ; Ahrens S; Paulussen M; Jürgens HF; Voûte PA; Gadner H; Craft AW
J Clin Oncol; 2000 Sep; 18(17):3108-14. PubMed ID: 10963639
[TBL] [Abstract][Full Text] [Related]
14. Periosteal Ewing's sarcoma.
Kolár J; Zídková H; Matĕjovsky Z; Povýsil C; Kolín J; Beran J
Rofo; 1989 Feb; 150(2):179-82. PubMed ID: 2537514
[TBL] [Abstract][Full Text] [Related]
15. Notch signalling is off and is uncoupled from HES1 expression in Ewing's sarcoma.
Bennani-Baiti IM; Aryee DN; Ban J; Machado I; Kauer M; Mühlbacher K; Amann G; Llombart-Bosch A; Kovar H
J Pathol; 2011 Nov; 225(3):353-63. PubMed ID: 21984123
[TBL] [Abstract][Full Text] [Related]
16. Survival and prognostic factors in adult patients with recurrent or refractory ewing sarcoma family tumours: a 13-years retrospective study in Turkey.
Yildiz I; Sen F; Ekenel M; Darendeliler E; Bavbek S; Agaoglu F; Ozger H; Eralp L; Bilgic B; Basaran M
In Vivo; 2014; 28(3):403-9. PubMed ID: 24815845
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic value of the molecular genetic detection of the t(11;22) translocation in Ewing's tumours.
Dockhorn-Dworniczak B; Schäfer KL; Dantcheva R; Blasius S; Winkelmann W; Strehl S; Burdach S; van Valen F; Jürgens H; Böcker W
Virchows Arch; 1994; 425(2):107-12. PubMed ID: 7524975
[TBL] [Abstract][Full Text] [Related]
18. Non-Metastatic Pelvic Ewing's Sarcoma : oncologic outcomes and evaluation of prognostic factors.
Dramis A; Grimer RJ; Malizos K; Tillman RM; Jeys L; Carter LR
Acta Orthop Belg; 2016 Aug; 82(2):216-221. PubMed ID: 27682283
[TBL] [Abstract][Full Text] [Related]
19. Hypoxia and hypoglycaemia in Ewing's sarcoma and osteosarcoma: regulation and phenotypic effects of Hypoxia-Inducible Factor.
Knowles HJ; Schaefer KL; Dirksen U; Athanasou NA
BMC Cancer; 2010 Jul; 10():372. PubMed ID: 20637078
[TBL] [Abstract][Full Text] [Related]
20. Phosphoinositide 3-hydroxide kinase blockade enhances apoptosis in the Ewing's sarcoma family of tumors.
Toretsky JA; Thakar M; Eskenazi AE; Frantz CN
Cancer Res; 1999 Nov; 59(22):5745-50. PubMed ID: 10582694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
